What we do

On July 7, Tech Barcelona's headquarters hosted a new training capsule from I4KIDS, the pediatric innovation hub coordinated by Hospital Sant Joan de Déu, organized in collaboration with Catalonia.health. The session brought together startup leaders, researchers and health professionals to discuss financing, regulation and international expansion in the field of pediatric health.

The company, a member of Catalonia.health, has obtained the CE marking for its surgical robotic system, a milestone that opens the door to its commercialization on the European market and marks the beginning of a new stage of growth.

The Catalonia.health barbecue celebrates its eleventh edition with 600 attendees and reaffirms itself as the networking space for Catalonia's health ecosystem

fetaLife Technologies, a spin-off created in 2025 by Hospital Clínic de Barcelona, ​​Hospital Sant Joan de Déu and the University of Barcelona, ​​a member of Catalonia.health, promotes the transfer to clinical practice of a disruptive technology aimed at improving survival and reducing the sequelae of extremely premature babies.

WIVI Vision, member of Catalonia.health, has achieved Class IIa health product certification for its visual therapy technology and has been selected by ACCIÓ as one of the ten companies in the Catalonia Exponential Leaders 2026 program.

The technology company IMAGINAE, a member of Catalonia.health, will participate as a technology partner in the NAIVE (Neotropical AI-assisted Vertebrate identification through ZooMS) project led by ICTA-UAB and scientifically directed by Dr. André Carlo Colonese, director of research at the Department of Prehistory and ICTA-UAB.

The HIPRA group, member of Catalonia.health, closed the 2025 financial year with a turnover of 516 million euros and a net profit of 53.9 million euros. The turnover represents an increase of 17% compared to the previous year and represents the highest annual turnover achieved by the group to date, consolidating its trajectory of growth and international expansion.

The Germans Trias i Pujol Research Institute (IGTP), member of Catalonia.health, celebrated on June 18 a new edition of the Innomed Awards, a day aimed at promoting biomedical innovation projects and strengthening the connection between research, the health system, entrepreneurship and investment. The event took place in the auditorium of the Josep Carreras Institute (IJC) on the Can Ruti Campus and brought together professionals from research, health, entrepreneurship and investment.

Catalonia.health member biotech company OneChain Immunotherapeutics has announced promising interim results from its ongoing clinical trial with OC-1, its CAR-T therapy, in patients with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LL), a rare and aggressive blood cancer that affects both children and adults. The data were presented on June 17 at the 2026 Congress of the European Hematology Association (EHA).

Catalonia.health and IDIAP Jordi Gol have organized the Primary Care Edition conference, which has connected six real clinical challenges of primary care with the companies that propose solutions

Helsinki, June 2026 – Our Project Coordinator, Roser Alba, participated this week in the third study visit of the European project RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), held in Helsinki with representatives of the eight partner regions of the consortium: Limburg (Netherlands), Helsinki-Uusimaa (Finland), Saxony-Anhalt (Germany), Western Slovenia, North-East Romania, Emilia-Romagna (Italy), Bosnia and Herzegovina and Catalonia.

The biopharmaceutical company Oryzon Genomics, a member of Catalonia.health, has presented updated positive clinical data from two clinical trials with its selective LSD1 inhibitor, iadademstat, in acute myeloid leukemia (AML), at the 2026 Annual Congress of the European Association of Hematology (EHA), held on June 11.

The Catalan biotechnology company AbilityPharma and the Vall d'Hebron Institut de Recerca (VHIR), both members of Catalonia.health, participate prominently in the European PHOENIX project, funded with 8.5 million euros by the European Union through Horizon Europe's Cancer Mission program.

The biotechnology company Gate2Brain, a member of Catalonia.health, has announced a strategic alliance with Shilpa Biocare Pvt Ltd, a subsidiary of Shilpa Medicare Limited, which includes an investment of 7 million euros and a 30.4% stake in the company. This is the largest investment raised by Gate2Brain since its foundation in 2020 and consolidates the growth achieved in less than six years of activity.

Catalonia.health's IMPULS program hosted a new Lessons Learned session focused on the real path to B Corp certification, with the participation of four leading companies in the health sector.

Biotech company CONNECTA Therapeutics, member of Catalonia.health, has announced the start of a Phase IIa clinical trial with its most advanced program, CTH120, in adult males with fragile X syndrome (FSX). The milestone comes after the positive safety results obtained in Phase I and represents a key step in the company's evolution.

Biopharmaceutical company Ona Therapeutics, member of Catalonia.health, has announced the closing of an oversubscribed $86.6 million Series B funding round aimed at advancing the clinical development of its first-in-class antibody-drug conjugates (ADCs) for the treatment of cancers resistant to current treatments.

The event brought together all the members of the consortium and highlighted the collaborative work between technology, clinic and ecosystem

Ambit Iberia, member of Catalonia.health, organized last June 3 in Barcelona a new edition of Ambit Meets: Tech Trends & Compliance in Life Science, its annual event aimed at professionals in the Life Sciences sector to share experiences, analyze trends and debate the challenges that will mark the future of the industry.

The pharmaceutical company Medichem, a member of Catalonia.health, has been awarded the Second COASHIQ Sustainability Award for its "Waste, Water and Climate Change Management Programs" project, during the 122nd COASHIQ Technical Assembly and Conference, held on May 19 and 20 in Valencia.